The Effect of Real-Time Continuous Glucose Monitoring in Pregnant Women With Diabetes
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess whether intermittent real-time continuous glucose monitoring (CGM) improves glycemic control and pregnancy outcome in unselected women with pregestational diabetes. RESEARCH DESIGN AND METHODS: A total of 123 women with type 1 diabetes and 31 women with type 2 diabetes were randomized to use real-time CGM for 6 days at 8, 12, 21, 27, and 33 weeks in addition to routine care, including self-monitored plasma glucose seven times daily, or routine care only. To optimize glycemic control, real-time CGM readings were evaluated by a diabetes caregiver. HbA1c, self-monitored plasma glucose, severe hypoglycemia, and pregnancy outcomes were recorded, with large-for-gestational-age infants as the primary outcome. RESULTS: Women assigned to real-time CGM (n = 79) had baseline HbA1c similar to that of women in the control arm (n = 75) (median 6.6 [range 5.3–10.0] vs. 6.8% [5.3–10.7]; P = 0.67) (49 [34–86] vs. 51 mmol/mol [34–93]). Forty-nine (64%) women used real-time CGM per protocol. At 33 weeks, HbA1c (6.1 [5.1–7.8] vs. 6.1% [4.8–8.2]; P = 0.39) (43 [32–62] vs. 43 mmol/mol [29–66]) and self-monitored plasma glucose (6.2 [4.7–7.9] vs. 6.2 mmol/L [4.9–7.9]; P = 0.64) were comparable regardless of real-time CGM use, and a similar fraction of women had experienced severe hypoglycemia (16 vs. 16%; P = 0.91). The prevalence of large-for-gestational-age infants (45 vs. 34%; P = 0.19) and other perinatal outcomes were comparable between the arms. CONCLUSIONS: In this randomized trial, intermittent use of real-time CGM in pregnancy, in addition to self-monitored plasma glucose seven times daily, did not improve glycemic control or pregnancy outcome in women with pregestational diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“There was also lower incidence of large for gestational age (odds ratio [OR], 0.51; 95% CI, 0$28–0.90; P = .0210)”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [123]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“The CONCEPTT study’s participants were randomly assigned to either CGM in addition to capillary glucose monitoring or capillary glucose monitoring alone and showed a modest reduction in A1C levels, increased time in target, reduced hyperglycemia, and less glycemic variability.123”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [123]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“and 1-day shorter length of hospital stay (P = .0091) in women with T1D on multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII).”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [123]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“fewer incidences of neonatal hypoglycemia (0.45; 95% CI, 0.22–0.89; P = .0250)”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [123]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“fewer neonatal intensive care admissions lasting more than 24 hours (0.48; 95% CI, 0.26–0.86; P = .0157)”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [123]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intrauterine growth curves based on ultrasonically estimated foetal weights
Maršál, K., Persson, P., Larsen, T., Lilja, H., Selbing, A., & Sultan, B. (1996) · Acta Paediatrica · doi:10.1111/j.1651-2227.1996.tb14164.x · Cited by 1,865 · cited 1×
“, infant birth weight $90th centile adjusted for sex and gestational age (31)] was predefined as the primary outcome of this study.”
MethodContinuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Clausen, T. D., Mathiesen, E. R., Hansen, T., Pedersen, O., Jensen, D. M., Lauenborg, J., & Damm, P. (2008) · Diabetes Care · doi:10.2337/dc07-1596 · Cited by 724
Self-citationPickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541 · cited 2×
“Recent data indicate the importance of frequent real-time CGM use (16).”
BackgroundDeiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
The effect of continuous glucose monitoring in well-controlled type 1 diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0108 · Cited by 399
Murphy, H. R., Rayman, G., Lewis, K., Kelly, S., Johal, B., Duffield, K., Fowler, D., Campbell, P. J., & Temple, R. C. (2008) · BMJ · doi:10.1136/bmj.a1680 · Cited by 358 · cited 6×
“However, the relatively low number of per-protocol users has also been observed in the nonpregnant population (17,18), and the average use of CGM was comparable to the former study on pregnant women (27).”
BackgroundResultInfluentialHbA1c levels are significantly lower in early and late pregnancy
Nielsen, L. R., Ekbom, P., Damm, P., Glümer, C., Frandsen, M. M., Jensen, D. M., & Mathiesen, E. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1200 · Cited by 331
Self-citationEffectiveness of Continuous Glucose Monitoring in a Clinical Care Environment
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1502 · Cited by 313
Cited by
Items 201–243 of 243
Pregestational Diabetes Mellitus
Norwitz, E. R., Saade, G. R., Miller, H. S., & Davidson, C. M. (2016) · Wiley eBooks · doi:10.1002/9781118849897.ch13 · Cited by 1
Richardson, K., & Richardson, K. (2024) · UA Campus Repository (The University of Arizona) · Cited by 1
Hypoglycaemia During Pregnancy in Women with Pregestational Diabetes
Ringholm, L., Damm, P., & Mathiesen, E. R. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch11
Self-citationManaging pregnancy in women with Type 1 diabetes
O'Sullivan, E. S., Hewapathirana, N. M., & Murphy, H. R. (2013) · Diabetes Management · doi:10.2217/dmt.13.15
Sensor augmented pump(SAP)で管理を行った1型糖尿病合併妊娠の1例
中江理絵, 宜樹, 楠., 勝野, 朋., 渡邉佳穂里, 完山昌隆, 拓, 角., 俊宏, 松., 越智, 史., 徳田八大, 隆文, 赤., et al. (2015) · 糖尿病 · doi:10.11213/tonyobyo.58.818
Navathe, R. S., Gerli, S., Pacella, E., & Berghella, V. (2016) · Springer eBooks · doi:10.1007/978-3-319-31377-1_14
Kopenhagener Strategie senkt nicht nur Frühgeburtlichkeit bei Diabetes signifikant
Stupin, J. H. (2017) · Info Diabetologie · doi:10.1007/s15034-017-1024-3
Diabetes mellitus gestacional : perfis glicêmicos e desfechos da gestação
de Andrade, L. T. (2017) · Americanae (AECID Library)
CGM nützt Schwangeren mit Typ-1-Diabetes und ihren Babys
Stupin, J. H. (2017) · Info Diabetologie · doi:10.1007/s15034-017-1217-9
Home Blood Glucose Monitoring and Digital-Health in Diabetes
Farmer, A. A., & Pal, K. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_13-1
Clinical and Biochemical Aspects of Gestational Diabetes Mellitus
Brink, H. S. (2018) · RePub (Erasmus University Rotterdam)
Assessment of glucose kinetics with real‐time continuous glucose monitoring during labor
Maki, J., Eto, E., Tamada, S., Mitsui, T., Hayata, K., Nakamura, K., Hiramatsu, Y., & Masuyama, H. (2019) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14058
“Based on published data, [10,11] we used α of 0.”
MethodМищенко, О. И., Елгина, С. И., Мозес, К. Б., Мозес, В. Г., & Рудаева, Е. В. (2020) · Медицина в Кузбассе
Tecnologia, diabete e gravidanza
Bonomo, M. A., Feig, D. S., Pintaudi, B., Mion, E., & Bertuzzi, F. (2021) · L Endocrinologo · doi:10.1007/s40619-021-00858-9
Evaluation of Changes in Maternal Blood Sugar and Renal Function Tests during Gestational Period
Prakash, S. (2021) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.4840602
НОВЫЕ ТЕХНОЛОГИИ ЛЕЧЕНИЯ САХАРНОГО ДИАБЕТА I ТИПА ВО ВРЕМЯ БЕРЕМЕННОСТИ
Помыткина, Т. Е., Рудаева, Е. В., Валерьевич, Р. С., Елгина, С. И., Мозес, К. Б., Мозес, В. Г., Рудаева, Е. Г., & Мищенко, О. И. (2021) · Matʹ i ditâ v Kuzbasse · doi:10.24411/2686-7338-2021-10002
Review of Tools for Early Detection and Screening of Diabetes
Famurewa, O., Atiq, A., & Mirza, F. (2020) · AIS Electronic Library (AISeL)
Use of new technologies in pregnancy
Ragusa, I. (2019) · The Journal of AMD · doi:10.36171/jamd19.22.3.09
Using the Novel Approach of an Artificial Pancreas to Manage Type 1 Diabetes Mellitus in Pregnancy
Lefkovits, Y. R., Stewart, Z., & Murphy, H. R. (2019) · European Medical Journal · doi:10.33590/emj/10312967
Monitoring glycémique continu et grossesse diabétique
A., F. (2013) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(13)70518-2
Brown, R. N. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735483240.793559258
Wynne, K. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735907959.793577422
Home Blood Glucose Monitoring and Digital-Health in Diabetes
Farmer, A. A., & Pal, K. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_13
Vinagre, I., Giménez, M., Pericot, A., Bellart, J., & Conget, I. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2014.06.005
Jones, B., & Dornhorst, A. (2020) · doi:10.1093/med/9780198746690.003.0272
Does Continuous Glucose Monitoring Help in Pregnant Women?
Hsu, W.-Y., Hung, J.-A., Sung, I.-C., & Chan, T. (2022) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog4907146
Agha-Jaffar, R., Johnston, D. G., & Robinson, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-89243-2_5
MESA 2: INNOVACIONES TECNOLÓGICAS EN EL TRATAMIENTO DE LA DIABETES MELLITUS TIPO 1
Morosini, M. L. R., PROIETTI, A. E., Ré, M., Schindler, A., Medek, G., Dios, A. D., Larreburo, S. V., Mengoni, K., González, L. S., Méndez, J., et al. (2023) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v49i3.634
Continuous Glucose Monitoring and Insulin Pumps in the Management of Diabetes in Pregnancy
Yamamoto, J. M., & Murphy, H. R. (2019) · doi:10.2337/9781580406932.part1_ch11
Monotorização continua da glicose em grávidas com diabetes
Andrade, C. F. G. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/a3by-n806
Abordagem terapêutica da Diabetes Mellitus tipo I durante a gravidez
João, M. C. P. D. S. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Sundberg, C., & Andersson, C. (2019) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Saccone, S., Finozzi, R., Barquet, J., Cóppola, F., & Mendoza, B. (2024) · Anales de la Facultad de Medicina
Tiselko, A. V., Rybachek, A. V., Kopteeva, E. V., Alekseenkova, E. N., Modorskaia, A. N., Bespalova, O. N., & Kapustin, R. V. (2025) · Journal of obstetrics and women s diseases · doi:10.17816/jowd688162
Gossen-Perez, E., Minglan, L., Lewis-Hills, E., Okesene-Gafa, K. A. M., & Oyston, C. (2026) · Discover Endocrinology and Metabolism · doi:10.1007/s44417-025-00013-0
Eng, P. C., Tag, W. Y., Sivaramasubramaniam, S., Aung, A. T., Teoh, C. L., Zhang, H. M., Yew, T. W., & Khoo, C. M. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70619
“Thus, in T1DM, use of CGM is especially relevant because it improves glycaemic control in third trimester [49], reduced risk of macrosomia [49], increased time- in-range, reduced length of stay [49–51] and improved patient satisfaction [52].”
Insulin and Pregnancy: A Narrative Review of Evidence and Perspectives
Sandler, V., Isaacs, D. M., & Carlson, A. L. (2026) · Diabetes Technology and Obesity Medicine · doi:10.1177/29986702261442844
Liu, Q., Sun, M., & Xu, Z. (2026) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-026-01673-4
Stalheim, A. M., Nilsen, R. M., Vangen, S., Vik, E. S., Alnæs‐Katjavivi, P., Iversen, M. M., Berg, T. J., & Strandberg, R. B. (2026) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.70215
Lee, T. T. M., Collett, C., Hayes, M., Hammond, M., Wagner, A. P., Shepstone, L., Myers, J., Benton, M., Ismail, K., Misra, S., et al. (2026) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-026-09469-4
Влияние сахарного диабета 1-го типа на течение беременности
Emelianova, D. V., Злобина, А. А., Гартвих, Я. А., Дутов, М. С., Konchakova, E. A., Атоян, К. Ю., & Дадажонов, М. М. (2026) · Репродуктивное здоровье Восточная Европа · doi:10.34883/pi.2026.16.2.018
Bannuru, R. R., Noble, M., Aleppo, G., Polsky, S., Fazioli, K., Shields, T. C., & ElSayed, N. A. (2026) · Diabetes Obesity and Cardiometabolic CARE · doi:10.2337/doc26-0018
Мониторинг гликемии в профилактике осложнений беременности при сахарном диабете 1 типа
Startseva, N. M., Ивановна, С. М., А., И. Ш. С., Сергеевич, Н. Д., Павловна, Р. Н., Сергеевич, А. А., & Александровна, А. А. (2026) · Obstetrics and gynecology News Opinions Training
Metadata
- Authors
- Secher, A. L., Ringholm, L., Andersen, H. U., Damm, P., & Mathiesen, E. R.
- Affiliations
- University of Copenhagen (DK)
- Rigshospitalet (DK)
- Steno Diabetes Center, Gentofte, Denmark
- Corresponding author
- Secher, Anna L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-06-12
- Volume
- 36
- Issue
- 7
- Pages
- 1877-1883
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3687305
- OpenAlex
- W2107291591
- Cited by
- 214
- References
- 36
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 15 · 2023: 9 · 2022: 17 · 2021: 18 · 2020: 12 · 2019: 18 · 2018: 26 · 2017: 15 · 2016: 20 · 2015: 14 · 2014: 11 · 2013: 12
- FWCI
- 21.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- real-time continuous glucose monitoring, pregnancy, pregestational diabetes, type 1 diabetes, type 2 diabetes, glycemic control, HbA1c, severe hypoglycemia, large for gestational age, perinatal outcomes, gestational diabetes management
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Pregnancy, Pregnancy Outcome, Blood Glucose Self-Monitoring, Treatment Outcome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
